Presentation is loading. Please wait.

Presentation is loading. Please wait.

Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. Analysis of mRNA and protein.

Published byGudrun Bertelsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. Analysis of mRNA and protein."— Presentation transcript:

1 Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. A. RT-PCR analysis of five genes of representative five couples of samples [5 OSF (O) and 5 NBM samples (N)]. M, DNA marker. B. mRNA ratios of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 in OSF versus normal controls. The gene expression level was normalized by GAPDH as internal control. C. Western blotting analysis of five proteins of representative three couples of samples (3 OSF and 3 NBM). D. Protein ratios of COMP, CXCL9, KRT19, and CYP 3A5 in OSF versus normal controls. The protein expression level was normalized by using β-actin as internal control. Ning Li et al. Cancer Epidemiol Biomarkers Prev 2008;17: ©2008 by American Association for Cancer Research

Download ppt "Analysis of mRNA and protein levels of Loricrin, COMP, CXCL9, KRT19, and CYP 3A5 genes in OSFs compared with normal controls. Analysis of mRNA and protein."

Similar presentations

Odds ratios for change in PD from earliest mammogram within levels of earliest PD. No evidence for an interaction of earliest PD and change in PD on breast.

Odds ratios for change in PD from earliest mammogram within levels of earliest PD. No evidence for an interaction of earliest PD and change in PD on breast.
Enhanced DNA damage in IDH1 mutant glioma cells.

Enhanced DNA damage in IDH1 mutant glioma cells.
KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.

KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.
IL-1β differentially regulates CXCL5 and CXCL8 protein secretion in NHTBE and NSCLC cells. IL-1β differentially regulates CXCL5 and CXCL8 protein secretion.

IL-1β differentially regulates CXCL5 and CXCL8 protein secretion in NHTBE and NSCLC cells. IL-1β differentially regulates CXCL5 and CXCL8 protein secretion.
IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.

IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
Inhibition of ILK by QLT-0267 reduces β-catenin accumulation and inhibits Snail1 expression in obstructive nephropathy. Inhibition of ILK by QLT-0267 reduces.

Inhibition of ILK by QLT-0267 reduces β-catenin accumulation and inhibits Snail1 expression in obstructive nephropathy. Inhibition of ILK by QLT-0267 reduces.
Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.

Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.
DHEA(S) and Allo induced the expression of the antiapoptotic Bcl-2 proteins in serum-deprived PC12 cells. DHEA(S) and Allo induced the expression of the.

DHEA(S) and Allo induced the expression of the antiapoptotic Bcl-2 proteins in serum-deprived PC12 cells. DHEA(S) and Allo induced the expression of the.
Flow diagram of the literature search and selection process in the PubMed and Scopus databases. Flow diagram of the literature search and selection process.

Flow diagram of the literature search and selection process in the PubMed and Scopus databases. Flow diagram of the literature search and selection process.
miRNA expression patterns in stools from healthy subjects.

miRNA expression patterns in stools from healthy subjects.
Pioglitazone inhibits aromatase expression in human preadipocytes.

Pioglitazone inhibits aromatase expression in human preadipocytes.
CHK1 downregulation upon ERG overexpression.

CHK1 downregulation upon ERG overexpression.
Yan Wen, M. D. , Rudy Quintero, M. D. , Bertha Chen, M. D

Yan Wen, M. D. , Rudy Quintero, M. D. , Bertha Chen, M. D
Quantitative RT-PCR results of relative gene expression normalized to wild-type (WT) expression levels for the LjMYB14 transgene (A) and genes specific.

Quantitative RT-PCR results of relative gene expression normalized to wild-type (WT) expression levels for the LjMYB14 transgene (A) and genes specific.
Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.

Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.
Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.

Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.
Fig. 1. PARN is differentially expressed in breast cancer versus non-cancerous tissue/cells. PARN is differentially expressed in breast cancer versus non-cancerous.

Fig. 1. PARN is differentially expressed in breast cancer versus non-cancerous tissue/cells. PARN is differentially expressed in breast cancer versus non-cancerous.
Nrf2−/− mice had higher TGF-β1 transcription and FN expression.

Nrf2−/− mice had higher TGF-β1 transcription and FN expression.
Elevation of protein levels of O-GlcNAcase in pre-diabetic and diabetic erythrocytes. Elevation of protein levels of O-GlcNAcase in pre-diabetic and diabetic.

Elevation of protein levels of O-GlcNAcase in pre-diabetic and diabetic erythrocytes. Elevation of protein levels of O-GlcNAcase in pre-diabetic and diabetic.
Expression of mRNA erythropoietin in the human retina.

Expression of mRNA erythropoietin in the human retina.

Similar presentations

Ads by Google